BE
Bonness Enterprises Portfolio holdings
AUM
$305M
This Quarter Return
-1.22%
1 Year Return
+20.16%
3 Year Return
+82.96%
5 Year Return
+156.72%
10 Year Return
+388.32%
AUM
$218M
AUM Growth
+$218M
(-1.8%)
Cap. Flow
-$32.4K
Cap. Flow
% of AUM
-0.01%
Top 10 Holdings %
Top 10 Hldgs %
70.33%
Holding
40
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Verizon
VZ
|
$32.4K |
Sector Composition
| 1 | Financials | 39.58% |
| 2 | Healthcare | 27.34% |
| 3 | Technology | 21.07% |
| 4 | Industrials | 3.58% |
| 5 | Consumer Staples | 3.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Progressive
PGR
$145B
| $79.1M | 36.24% |
567,757
| – | – |
|
2
Stryker
SYK
$150B
| $18.3M | 8.41% |
67,130
| – | – |
|
3
Microsoft
MSFT
$3.77T
| $12.9M | 5.92% |
40,900
| – | – |
|
4
Apple
AAPL
$3.45T
| $9.41M | 4.31% |
54,940
| – | – |
|
5
Merck
MRK
$210B
| $7.16M | 3.28% |
69,500
| – | – |
|
6
Johnson & Johnson
JNJ
$427B
| $6.05M | 2.77% |
38,838
| – | – |
|
7
Thermo Fisher Scientific
TMO
$186B
| $5.56M | 2.55% |
10,985
| – | – |
|
8
AbbVie
ABBV
$372B
| $5.5M | 2.52% |
36,900
| – | – |
|
9
Marsh & McLennan
MMC
$101B
| $4.85M | 2.22% |
25,500
| – | – |
|
10
Intel
INTC
$107B
| $4.62M | 2.12% |
129,950
| – | – |
|
11
Cisco
CSCO
$274B
| $4.45M | 2.04% |
82,700
| – | – |
|
12
Applied Materials
AMAT
$128B
| $4.33M | 1.99% |
31,300
| – | – |
|
13
Nucor
NUE
$34.1B
| $4.29M | 1.97% |
27,435
| – | – |
|
14
Emerson Electric
EMR
$74.3B
| $4.15M | 1.9% |
43,000
| – | – |
|
15
IBM
IBM
$227B
| $4.15M | 1.9% |
29,564
| – | – |
|
16
Unilever
UL
$155B
| $3.76M | 1.72% |
76,040
| – | – |
|
17
Pfizer
PFE
$141B
| $3.64M | 1.67% |
109,708
| – | – |
|
18
Abbott
ABT
$231B
| $3.17M | 1.45% |
32,700
| – | – |
|
19
Bristol-Myers Squibb
BMY
$96B
| $3.15M | 1.44% |
54,300
| – | – |
|
20
Procter & Gamble
PG
$368B
| $2.39M | 1.1% |
16,400
| – | – |
|
21
United Parcel Service
UPS
$74.1B
| $2.33M | 1.07% |
14,950
| – | – |
|
22
Philips
PHG
$26.2B
| $2.03M | 0.93% |
101,565
| – | – |
|
23
Agilent Technologies
A
$35.7B
| $2M | 0.92% |
17,900
| – | – |
|
24
GSK
GSK
$79.9B
| $1.92M | 0.88% |
52,960
| – | – |
|
25
John Wiley & Sons Class A
WLY
$2.16B
| $1.8M | 0.82% |
48,400
| – | – |
|